Bellevue Group’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-212,559
| Closed | -$4.84M | – | 165 |
|
|
2024
Q2 | $4.84M | Sell |
212,559
-234,817
| -52% | -$5.35M | 0.08% | 96 |
|
|
2024
Q1 | $13.6M | Sell |
447,376
-370,507
| -45% | -$11.3M | 0.21% | 88 |
|
|
2023
Q4 | $29.2M | Buy |
817,883
+70,323
| +9% | +$2.51M | 0.45% | 64 |
|
|
2023
Q3 | $32.7M | Sell |
747,560
-1,053
| -0.1% | -$46.1K | 0.53% | 53 |
|
|
2023
Q2 | $37M | Buy |
748,613
+101,391
| +16% | +$5M | 0.53% | 59 |
|
|
2023
Q1 | $26.8M | Buy |
647,222
+3,113
| +0.5% | +$129K | 0.39% | 69 |
|
|
2022
Q4 | $28.6M | Buy |
644,109
+1,662
| +0.3% | +$73.8K | 0.38% | 71 |
|
|
2022
Q3 | $25.1M | Buy |
642,447
+551
| +0.1% | +$21.5K | 0.36% | 74 |
|
|
2022
Q2 | $26.2M | Buy |
641,896
+43,291
| +7% | +$1.77M | 0.37% | 74 |
|
|
2022
Q1 | $39.3M | Buy |
598,605
+100,049
| +20% | +$6.57M | 0.46% | 68 |
|
|
2021
Q4 | $34.7M | Buy |
498,556
+80,540
| +19% | +$5.6M | 0.36% | 79 |
|
|
2021
Q3 | $29.1M | Buy |
418,016
+43,598
| +12% | +$3.03M | 0.3% | 92 |
|
|
2021
Q2 | $29.7M | Sell |
374,418
-123,294
| -25% | -$9.78M | 0.29% | 93 |
|
|
2021
Q1 | $32.6M | Sell |
497,712
-58,662
| -11% | -$3.84M | 0.35% | 85 |
|
|
2020
Q4 | $31M | Buy |
+556,374
| New | +$31M | 0.35% | 77 |
|